COAG Earnings Date: Nov 10, 2026 (Estimated) — Hemab Therapeutics Holdings, Inc. Common Stock

NASDAQ

Updated Oct 30, 2026

Price $41.09

Market Cap $1.8B

P/E -29.3

52W Range $23.00 – $55.42

Next Earnings Nov 10, 2026 · After close (est.)

When is COAG's next earnings date?

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is expected to report Q3 2026 earnings on Tuesday, November 10, 2026 at 6:17 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.51.

How did COAG do in its last earnings report?

In its most recent report on Aug 11, 2026 (Q2 2026), Hemab Therapeutics Holdings, Inc. Common Stock posted EPS of -$0.80 versus the -$0.73 estimate, a miss of 2.6%. Revenue was $0. The stock's 1-day post-earnings move was +3.7%.

How much does COAG stock move after earnings?

COAG beat EPS estimates in 0 of its last 1 reported quarter. Over the last 2 reports the stock moved an average of 2.2% (up or down) in the day after earnings.

About Hemab Therapeutics Holdings, Inc. Common Stock

Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for the preventive management of Glanzmann thrombasthenia and has progressed to Phase 2 for the prophylactic treatment of Factor VII deficiency. Additionally, Hemab is advancing HMB-002, a monovalent antibody, through Phase 1/2 clinical development. This drug is designed for the subcutaneous prophylactic treatment of Von Willebrand disease. Beyond these clinical assets, the company actively pursues numerous preclinical and discovery-stage programs. Established in 2020, Hemab Therapeutics Holdings, Inc. maintains its headquarters in Cambridge, Massachusetts.